Theory#bsx8dcli
The pharmaceutical industry is a multi-hundred-billion-dollar global market, with cancer treatment being a significant contributor to its revenue. This has led some to speculate that effective cancer cures are being suppressed in favor of ongoing treatment.
Several researchers who claimed breakthroughs in alternative cancer treatments have faced intense scrutiny, including legal action and discrediting of their work. One notable example is Royal Raymond Rife, who in the 1930s claimed to have developed a frequency device that could destroy cancer cells.
The close ties between pharmaceutical executives and FDA regulators, often referred to as the revolving door, have raised concerns about conflicts of interest and the potential suppression of life-saving treatments.
Reason
The enormous profits to be made from cancer treatment create a strong incentive for pharmaceutical companies to prioritize ongoing treatment over a one-time cure. This motivation is compounded by the influence and connections that these companies have with regulatory agencies.